Home › Study finds that drug labelling change may add $4bn to US health care costs
 

Keywords :   


Study finds that drug labelling change may add $4bn to US health care costs

2014-02-07 01:00:00| Packaging Gateway

The Food and Drug Administration's (FDA) recently proposed regulation affecting generic drug labelling may result in an estimated $4bn in additional US health care costs a year, according to an analysis by economic consulting firm Matrix Global Advis

Tags: add change health care

Category:Industrial Goods and Services

Latest from this category

All news
15.09Your MANA RepFinder Profile
13.09A League of Their Own Womens Special Interest Group Invites You to Attend a MANAchat on September 26
Industrial Goods and Services »
21.09Strategies to minimize fallback pigs in the nursery
21.09This Week in Agribusiness, Sept. 21, 2024
21.09This Week in Agribusiness, Sept. 21, 2024
21.09RABapp provides rapid response insight in animal health emergencies
21.09Atlantic Tropical Weather Outlook
21.09Eastern North Pacific Tropical Weather Outlook
21.09Weekly Recap: PPG, Axalta, AkzoNobel Top This Weeks Stories
21.09Atlantic Tropical Weather Outlook
More »